FDARecall 99990Medicines
What to do
The FDA record of this recall has no instruction for consumers. Compare the lot codes below with your product. If they match, do not use it, and follow the notice of the firm or ask the store where you bought it. Talk to your pharmacist or doctor before stopping a medicine.Note from Recalls Watch, not agency text.
Read the official notice on accessdata.fda.gov (opens in a new tab)
Hazard
Why it was recalled
Lack of assurance of sterility. Lack of process control
FDA classification: Class II. Use may cause temporary or medically reversible health consequences, or the chance of serious consequences is remote. Status: Ongoing.
Is it yours? Products and codes
Type the lot, batch, date code, model number or UPC printed on the product. It is compared here, in your browser, with the codes this notice lists. The code is also added to the page address (?lot=…), so a copied link or result carries it.
General information on recalls from the agency: U.S. Food and Drug Administration (opens in a new tab).
Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.
- Lot or code
- Lot# TZN-080326-20/2-2, Beyond Use Date: 12/01/2026.
- FDA recall number
- D-0040-2027
- Quantity
- 64 vials
Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.
- Lot or code
- Lot# SER-081726-1-10, Beyond Use Date: 10/01/2026.
- FDA recall number
- D-0041-2027
- Quantity
- 7 vials
Distribution (FDA): Nationwide in the USA.
About this record
- Issued by
- U.S. Food and Drug Administration
- Firm
- Houston Rx LLC
- Title
- Composed by Recalls Watch from fields of the record; FDA records have no title.